Anika Therapeutics, Inc. (ANIK) Reports Improved Q4 EPS of $0.21
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $14.42 --0%
EPS Growth %: +115.4%
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +115.4%
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.21, versus $0.10 reported last year. Revenue for the quarter came in at $18.4 million, versus $14.7 million reported last year.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
- CRH agrees to buy Arcosa in $8.5B all-cash deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
